Kaitlyn Gayvert Ph.D. in Computational Biology and Medicine is also Graduate of the Tri-Institutional Computational Biology and Medicine Program, a collaborative program run by Cornell University, Weill Cornell Medicine and Memorial Sloan-Kettering Cancer Center.
Member of the Elemento Lab, a cancer systems biology lab at Weill Cornell Medicine. My work centered around the integration of sequencing data with other publicly available large datasets. Kaitlyn has used this specifically for in silico drug discovery, identification of novel therapeutic targets, prediction of combination therapy synergy, and prediction of compound toxicity. She had been awarded multiple times including Health Tech Hackathon РGrand Prize, Forbes 30 Under 30 in Healthcare along with Neel Madhukar, F1000 Poster Prize Winner, The PhRMA Foundation Pre-Doctoral Informatics Fellowship and others.